|
Insider Trading: Heartware Ltd
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Heartware Ltd in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Heartware Ltd since year 2005. Table 2 shows the detailed insider transactions of Heartware Ltd since 2005.
The reporting company's ticker symbol is HTWR.
The reporting company's CIK number is 1389072.
The total value of stock buying since 2005 is $6,144,065.
The total value of stock sales is $236,082,592.
The total value of stock exercises is $5,267,370.
1 year stock price chart,
1 day stock price chart
HTWR 1 year chart HTWR 1 day chart
Figure 1. Monthly insider transaction values at Heartware Ltd (HTWR) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
07 08 09 10 11 12 01 2012 02 03 04 05 06 07 08 09 10 11 12 01 2013 02 03 04 05 06 -
Figure 2. Average prices of insider buys, sales, and option exercises at Heartware Ltd (HTWR) in the past 24 months. See table 2 for insider transaction details.
07 08 09 10 11 12 01 2012 02 03 04 05 06 07 08 09 10 11 12 01 2013 02 03 04 05 06 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Heartware Ltd (HTWR).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2013-06 | 0 | 0 | 2,656 | 240,128 | 0 | 0 |
| 2013-05 | 0 | 0 | 62,234 | 6,029,695 | 39,529 | 661,638 |
| 2013-03 | 0 | 0 | 2,500 | 221,887 | 5,250 | 0 |
| 2013-02 | 0 | 0 | 1,000 | 90,590 | 0 | 0 |
| 2012-12 | 0 | 0 | 367,278 | 29,975,131 | 32,549 | 0 |
| 2012-11 | 0 | 0 | 7,062 | 595,646 | 13,216 | 0 |
| 2012-09 | 0 | 0 | 38,923 | 3,590,226 | 83,500 | 303,600 |
| 2012-08 | 0 | 0 | 13,500 | 1,206,411 | 7,500 | 301,759 |
| 2012-07 | 0 | 0 | 43,519 | 3,925,809 | 13,062 | 492,399 |
| 2012-06 | 0 | 0 | 13,299 | 1,129,925 | 5,000 | 97,025 |
| 2012-05 | 0 | 0 | 29,428 | 2,331,179 | 18,008 | 95,500 |
| 2012-04 | 0 | 0 | 33,805 | 2,636,965 | 3,786 | 132,394 |
| 2012-03 | 0 | 0 | 8,257 | 580,454 | 5,250 | 0 |
| 2012-02 | 0 | 0 | 41,684 | 3,083,901 | 4,120 | 169,952 |
| 2012-01 | 0 | 0 | 12,171 | 856,258 | 0 | 0 |
| 2011-12 | 0 | 0 | 29,153 | 2,008,952 | 20,515 | 219,474 |
| 2011-11 | 0 | 0 | 7,500 | 474,975 | 0 | 0 |
| 2011-10 | 0 | 0 | 6,794 | 475,866 | 0 | 0 |
| 2011-09 | 0 | 0 | 74,878 | 4,173,543 | 108,500 | 0 |
| 2011-08 | 1,500 | 90,630 | 5,000 | 316,350 | 0 | 0 |
| 2011-06 | 0 | 0 | 10,000 | 713,100 | 0 | 0 |
| 2011-05 | 2,500 | 195,450 | 6,571 | 492,937 | 2,338 | 0 |
| 2011-02 | 0 | 0 | 10,890 | 954,004 | 17,498 | 0 |
| 2011-01 | 0 | 0 | 18,084 | 1,638,551 | 12,544 | 450,070 |
| 2010-12 | 0 | 0 | 2,010,000 | 156,576,100 | 0 | 0 |
| 2010-09 | 0 | 0 | 70,988 | 5,069,541 | 109,786 | 35,561 |
| 2010-07 | 0 | 0 | 0 | 0 | 562 | 0 |
| 2010-06 | 0 | 0 | 11,602 | 736,537 | 10,745 | 275,645 |
| 2010-05 | 0 | 0 | 13,488 | 745,717 | 6,428 | 155,814 |
| 2010-04 | 0 | 0 | 28,570 | 1,438,988 | 21,834 | 529,593 |
| 2010-03 | 0 | 0 | 16,327 | 653,186 | 0 | 0 |
| 2010-02 | 0 | 0 | 15,570 | 607,239 | 52,494 | 0 |
| 2010-01 | 0 | 0 | 12,458 | 467,822 | 5,458 | 172,425 |
| 2009-12 | 0 | 0 | 15,841 | 503,983 | 10,529 | 254,781 |
| 2009-11 | 0 | 0 | 24,331 | 777,656 | 62,075 | 754,687 |
| 2009-09 | 0 | 0 | 22,513 | 618,541 | 0 | 0 |
| 2009-08 | 3 | 71 | 0 | 0 | 22,000 | 129,360 |
| 2009-07 | 0 | 0 | 6,410 | 144,799 | 0 | 0 |
| 2009-06 | 0 | 0 | 0 | 0 | 6,284 | 35,693 |
| 2008-09 | 220,000 | 107,566 | 0 | 0 | 0 | 0 |
| 2008-08 | 4,129,000 | 2,132,110 | 0 | 0 | 0 | 0 |
| 2008-07 | 5,350,000 | 2,568,000 | 0 | 0 | 0 | 0 |
| 2008-06 | 20,000 | 9,600 | 0 | 0 | 0 | 0 |
| 2008-05 | 211,989 | 77,068 | 0 | 0 | 0 | 0 |
| 2008-04 | 1,000,000 | 314,000 | 0 | 0 | 0 | 0 |
| 2008-02 | 93,000 | 35,340 | 0 | 0 | 0 | 0 |
| 2007-08 | 63,000 | 28,980 | 0 | 0 | 0 | 0 |
| 2007-07 | 1,036,150 | 549,159 | 0 | 0 | 0 | 0 |
| 2007-06 | 72,183 | 36,091 | 0 | 0 | 0 | 0 |
Go to page: 1
2
3
Table 2. Detailed insider stock purchases, sales, and option exercises
for Heartware Ltd (HTWR)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2013-06-06 | Thomas Robert Bain (Director) | Sale | 2,656 | 90.41 | 240,128 |
| 2013-05-30 | Thomas Robert Bain (Director) | Sale | 57 | 94.05 | 5,360 |
| 2013-05-29 | Thomas Robert Bain (Director) | Sale | 714 | 93.50 | 66,762 |
| 2013-05-28 | Hathaway David R (Chief Medical Officer) | Sale | 5,934 | 95.05 | 564,026 |
| 2013-05-28 | Hathaway David R (Chief Medical Officer) | Option Exercise | 4,491 | 19.22 | 86,317 |
| 2013-05-28 | Thomas Robert Bain (Director) | Sale | 2,786 | 93.02 | 259,145 |
| 2013-05-22 | Hathaway David R (Chief Medical Officer) | Sale | 2,400 | 95.15 | 228,360 |
| 2013-05-22 | Hathaway David R (Chief Medical Officer) | Option Exercise | 2,400 | 19.55 | 46,920 |
| 2013-05-21 | Hathaway David R (Chief Medical Officer) | Sale | 17,140 | 96.31 | 1,650,753 |
| 2013-05-21 | Hathaway David R (Chief Medical Officer) | Option Exercise | 17,140 | 19.51 | 334,401 |
| 2013-05-21 | Thomas Robert Bain (Director) | Sale | 200 | 97.69 | 19,538 |
| 2013-05-20 | Knopf Lawrence J (General Counsel) | Sale | 2,000 | 97.72 | 195,440 |
| 2013-05-20 | Hathaway David R (Chief Medical Officer) | Sale | 10,000 | 97.89 | 978,900 |
| 2013-05-20 | Hathaway David R (Chief Medical Officer) | Option Exercise | 10,000 | 19.40 | 194,000 |
| 2013-05-20 | Wade Denis Newell (Director) | Sale | 4,000 | 99.00 | 396,000 |
| 2013-05-20 | Thomas Robert Bain (Director) | Sale | 6,429 | 98.08 | 630,582 |
| 2013-05-20 | Larose Jeffrey (Chief Scientific Officer) | Sale | 9,574 | 97.94 | 937,629 |
| 2013-05-12 | Harrison Seth Loring (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-12 | Wade Denis Newell (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-12 | Stockman Robert Bernard (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-12 | Thomas Robert Bain (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-12 | Barberich Timothy J (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-12 | Larkin C Raymond Jr (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-04 | Harrison Seth Loring (Director) | Option Exercise | 333 | .00 | 0 |
| 2013-05-04 | Wade Denis Newell (Director) | Option Exercise | 333 | .00 | 0 |
| 2013-05-04 | Stockman Robert Bernard (Director) | Option Exercise | 333 | .00 | 0 |
| 2013-05-04 | Thomas Robert Bain (Director) | Option Exercise | 333 | .00 | 0 |
| 2013-05-04 | Barberich Timothy J (Director) | Option Exercise | 333 | .00 | 0 |
| 2013-05-04 | Larkin C Raymond Jr (Director) | Option Exercise | 333 | .00 | 0 |
| 2013-05-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 97.20 | 97,200 |
| 2013-05-01 | Harrison Seth Loring (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-01 | Wade Denis Newell (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-01 | Stockman Robert Bernard (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-01 | Thomas Robert Bain (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-01 | Feldmann Cynthia L (Director) | Option Exercise | 500 | .00 | 0 |
| 2013-05-01 | Barberich Timothy J (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-05-01 | Larkin C Raymond Jr (Director) | Option Exercise | 250 | .00 | 0 |
| 2013-03-28 | Knopf Lawrence J (General Counsel) | Sale | 2,500 | 88.76 | 221,887 |
| 2013-03-28 | Knopf Lawrence J (General Counsel) | Option Exercise | 5,250 | .00 | 0 |
| 2013-02-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 90.59 | 90,590 |
| 2012-12-21 | Yocher Robert E (SVP, Regulatory & Quality) | Sale | 426 | 81.98 | 34,921 |
| 2012-12-21 | Yocher Robert E (SVP, Regulatory & Quality) | Option Exercise | 1,000 | .00 | 0 |
| 2012-12-21 | Knopf Lawrence J (General Counsel) | Sale | 639 | 81.98 | 52,382 |
| 2012-12-21 | Knopf Lawrence J (General Counsel) | Option Exercise | 1,500 | .00 | 0 |
| 2012-12-21 | Hathaway David R (Chief Medical Officer) | Sale | 532 | 81.98 | 43,610 |
| 2012-12-21 | Hathaway David R (Chief Medical Officer) | Option Exercise | 1,250 | .00 | 0 |
| 2012-12-21 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,064 | 81.98 | 87,226 |
| 2012-12-21 | Schuermann James (SVP, Sales & Marketing) | Option Exercise | 2,500 | .00 | 0 |
| 2012-12-21 | Larose Jeffrey (Chief Scientific Officer) | Sale | 1,627 | 81.98 | 133,381 |
| 2012-12-21 | Larose Jeffrey (Chief Scientific Officer) | Option Exercise | 4,375 | .00 | 0 |
| 2012-12-21 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,829 | 81.98 | 313,882 |
| 2012-12-21 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 9,000 | .00 | 0 |
| 2012-12-21 | Farrell Lauren (VP, Finance) | Sale | 405 | 81.97 | 33,197 |
| 2012-12-21 | Farrell Lauren (VP, Finance) | Option Exercise | 1,250 | .00 | 0 |
| 2012-12-20 | Hathaway David R (Chief Medical Officer) | Sale | 537 | 82.09 | 44,082 |
| 2012-12-20 | Hathaway David R (Chief Medical Officer) | Option Exercise | 1,262 | .00 | 0 |
| 2012-12-20 | Schuermann James (SVP, Sales & Marketing) | Sale | 532 | 82.09 | 43,671 |
| 2012-12-20 | Schuermann James (SVP, Sales & Marketing) | Option Exercise | 1,250 | .00 | 0 |
| 2012-12-20 | Larose Jeffrey (Chief Scientific Officer) | Sale | 1,042 | 82.09 | 85,537 |
| 2012-12-20 | Larose Jeffrey (Chief Scientific Officer) | Option Exercise | 2,800 | .00 | 0 |
| 2012-12-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,388 | 82.09 | 196,030 |
| 2012-12-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 5,612 | .00 | 0 |
| 2012-12-20 | Farrell Lauren (VP, Finance) | Sale | 243 | 82.08 | 19,945 |
| 2012-12-20 | Farrell Lauren (VP, Finance) | Option Exercise | 750 | .00 | 0 |
| 2012-12-14 | Harrison Seth Loring (Director) | Sale | 75,922 | 81.06 | 6,153,857 |
| 2012-12-13 | Hathaway David R (Chief Medical Officer) | Sale | 5,640 | 81.10 | 457,403 |
| 2012-12-13 | Harrison Seth Loring (Director) | Sale | 108,571 | 81.69 | 8,869,164 |
| 2012-12-13 | Wade Denis Newell (Director) | Sale | 2,163 | 81.00 | 175,203 |
| 2012-12-12 | Hathaway David R (Chief Medical Officer) | Sale | 6,000 | 81.81 | 490,860 |
| 2012-12-12 | Harrison Seth Loring (Director) | Sale | 11,480 | 81.82 | 939,293 |
| 2012-12-12 | Wade Denis Newell (Director) | Sale | 337 | 82.50 | 27,802 |
| 2012-12-11 | Hathaway David R (Chief Medical Officer) | Sale | 6,000 | 82.17 | 493,020 |
| 2012-12-11 | Harrison Seth Loring (Director) | Sale | 55,358 | 82.18 | 4,549,320 |
| 2012-12-10 | Harrison Seth Loring (Director) | Sale | 25,500 | 83.03 | 2,117,265 |
| 2012-12-07 | Harrison Seth Loring (Director) | Sale | 48,130 | 80.92 | 3,894,438 |
| 2012-12-04 | Thomas Robert Bain (Director) | Sale | 3,600 | 80.36 | 289,296 |
| 2012-12-03 | Schuermann James (SVP, Sales & Marketing) | Sale | 2,500 | 81.64 | 204,100 |
| 2012-12-03 | Thomas Robert Bain (Director) | Sale | 1,400 | 80.60 | 112,839 |
| 2012-12-03 | Larose Jeffrey (Chief Scientific Officer) | Sale | 1,413 | 80.26 | 113,407 |
| 2012-11-21 | Schuermann James (SVP, Sales & Marketing) | Sale | 800 | 84.37 | 67,494 |
| 2012-11-21 | Larose Jeffrey (Chief Scientific Officer) | Sale | 909 | 84.37 | 76,690 |
| 2012-11-21 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,817 | 84.37 | 322,032 |
| 2012-11-21 | Farrell Lauren (VP, Finance) | Sale | 536 | 84.74 | 45,420 |
| 2012-11-20 | Schuermann James (SVP, Sales & Marketing) | Option Exercise | 1,786 | .00 | 0 |
| 2012-11-20 | Larose Jeffrey (Chief Scientific Officer) | Option Exercise | 2,322 | .00 | 0 |
| 2012-11-20 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 8,572 | .00 | 0 |
| 2012-11-20 | Farrell Lauren (VP, Finance) | Option Exercise | 536 | .00 | 0 |
| 2012-11-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 84.01 | 84,010 |
| 2012-09-18 | Hathaway David R (Chief Medical Officer) | Sale | 916 | 92.39 | 84,629 |
| 2012-09-18 | Schuermann James (SVP, Sales & Marketing) | Sale | 915 | 92.39 | 84,536 |
| 2012-09-18 | Larose Jeffrey (Chief Scientific Officer) | Sale | 1,200 | 92.39 | 110,868 |
| 2012-09-18 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 11,162 | 92.52 | 1,032,708 |
| 2012-09-18 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 7,500 | 40.48 | 303,600 |
| 2012-09-18 | Farrell Lauren (VP, Finance) | Sale | 69 | 92.38 | 6,374 |
| 2012-09-17 | Hathaway David R (Chief Medical Officer) | Sale | 3,338 | 92.09 | 307,396 |
| 2012-09-17 | Schuermann James (SVP, Sales & Marketing) | Sale | 3,339 | 92.10 | 307,505 |
| 2012-09-17 | Larose Jeffrey (Chief Scientific Officer) | Sale | 4,377 | 92.09 | 403,077 |
| 2012-09-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 13,352 | 92.10 | 1,229,652 |
| 2012-09-17 | Farrell Lauren (VP, Finance) | Sale | 255 | 92.08 | 23,481 |
| 2012-09-16 | Hathaway David R (Chief Medical Officer) | Option Exercise | 10,000 | .00 | 0 |
| 2012-09-16 | Schuermann James (SVP, Sales & Marketing) | Option Exercise | 10,000 | .00 | 0 |
| 2012-09-16 | Larose Jeffrey (Chief Scientific Officer) | Option Exercise | 15,000 | .00 | 0 |
| 2012-09-16 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 40,000 | .00 | 0 |
| 2012-09-16 | Farrell Lauren (VP, Finance) | Option Exercise | 1,000 | .00 | 0 |
| 2012-08-28 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,146 | 90.24 | 283,895 |
| 2012-08-28 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 3,146 | 40.01 | 125,871 |
| 2012-08-24 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 1,854 | 90.09 | 167,026 |
| 2012-08-24 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 1,854 | 40.38 | 74,864 |
| 2012-08-23 | Thomas Robert Bain (Director) | Sale | 5,000 | 88.80 | 444,000 |
| 2012-08-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,500 | 88.98 | 222,450 |
| 2012-08-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 2,500 | 40.41 | 101,024 |
| 2012-08-01 | Schuermann James (SVP, Sales & Marketing) | Sale | 1,000 | 89.04 | 89,040 |
| 2012-07-31 | Larkin C Raymond Jr (Director) | Option Exercise | 562 | .00 | 0 |
| 2012-07-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 7,500 | 90.67 | 680,025 |
| 2012-07-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 7,500 | 39.38 | 295,350 |
| 2012-07-16 | Harrison Seth Loring (Director) | Sale | 19,401 | 90.21 | 1,750,164 |
| 2012-07-13 | Harrison Seth Loring (Director) | Sale | 9,199 | 90.00 | 827,910 |
| 2012-07-12 | Harrison Seth Loring (Director) | Sale | 194 | 90.00 | 17,460 |
| 2012-07-03 | Harrison Seth Loring (Director) | Sale | 525 | 90.00 | 47,250 |
| 2012-07-02 | Schuermann James (VP, Sales & Marketing) | Sale | 1,000 | 90.00 | 90,000 |
| 2012-07-02 | Harrison Seth Loring (Director) | Sale | 700 | 90.00 | 63,000 |
| 2012-07-02 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 5,000 | 90.00 | 450,000 |
| 2012-07-02 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 5,000 | 39.41 | 197,049 |
| 2012-06-25 | Yocher Robert E (SVP, Regulatory & Quality) | Sale | 1,060 | 86.41 | 91,594 |
| 2012-06-23 | Yocher Robert E (SVP, Regulatory & Quality) | Option Exercise | 2,500 | .00 | 0 |
| 2012-06-18 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,500 | 85.81 | 214,525 |
| 2012-06-18 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 2,500 | 38.81 | 97,025 |
| 2012-06-13 | Thomas Robert Bain (Director) | Sale | 714 | 85.24 | 60,861 |
| 2012-06-12 | Thomas Robert Bain (Director) | Sale | 5,000 | 85.61 | 428,050 |
| 2012-06-08 | Schuermann James (VP, Sales & Marketing) | Sale | 1,000 | 85.00 | 85,000 |
| 2012-06-07 | Stockman Robert Bernard (Director) | Sale | 3,025 | 82.61 | 249,895 |
| 2012-05-25 | Thomas Robert Bain (Director) | Sale | 428 | 78.54 | 33,615 |
| 2012-05-23 | Thomas Robert Bain (Director) | Sale | 957 | 78.34 | 74,971 |
| 2012-05-21 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 1,322 | 79.83 | 105,535 |
| 2012-05-18 | Thomas Robert Bain (Director) | Sale | 6,429 | 78.66 | 505,737 |
| 2012-05-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 2,500 | 80.23 | 200,575 |
| 2012-05-17 | Godshall Douglas Evan (President & Chief Exec Officer) | Option Exercise | 2,500 | 38.20 | 95,500 |
| 2012-05-16 | Thomas Robert Bain (Director) | Sale | 5,000 | 80.00 | 400,000 |
| 2012-05-15 | Thomas Robert Bain (Director) | Sale | 5,000 | 80.73 | 403,650 |
| 2012-05-12 | Harrison Seth Loring (Director) | Option Exercise | 250 | .00 | 0 |
| 2012-05-12 | Bennett Christine Constance (Director) | Option Exercise | 250 | .00 | 0 |
| 2012-05-12 | Wade Denis Newell (Director) | Option Exercise | 250 | .00 | 0 |
| 2012-05-12 | Stockman Robert Bernard (Director) | Option Exercise | 250 | .00 | 0 |
| 2012-05-12 | Thomas Robert Bain (Director) | Option Exercise | 250 | .00 | 0 |
| 2012-05-12 | Barberich Timothy J (Director) | Option Exercise | 250 | .00 | 0 |
| 2012-05-12 | Larkin C Raymond Jr (Director) | Option Exercise | 250 | .00 | 0 |
| 2012-05-11 | Farrell Lauren (VP, Finance) | Sale | 475 | 81.73 | 38,821 |
| 2012-05-09 | Schuermann James (VP, Sales & Marketing) | Sale | 313 | 77.18 | 24,157 |
| 2012-05-09 | Larose Jeffrey (Chief Scientifc Officer) | Sale | 820 | 77.18 | 63,287 |
| 2012-05-09 | Godshall Douglas Evan (President & Chief Exec Officer) | Sale | 3,445 | 77.18 | 265,885 |
Go to page: 1
2
3
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Heartware Ltd (symbol HTWR,
CIK number 1389072) see
the Securities and Exchange Commission (SEC) website.
|
|
